United States Systemic Mycoses Market Report 2019

Table of Contents

United States Systemic Mycoses Market Report 2017
1 Systemic Mycoses Overview
1.1 Product Overview and Scope of Systemic Mycoses
1.2 Classification of Systemic Mycoses by Product Category
1.2.1 United States Systemic Mycoses Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Systemic Mycoses Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Decadron
1.2.4 Prednisone
1.2.5 Dexamethasone
1.2.6 Trexall
1.2.7 Other
1.3 United States Systemic Mycoses Market by Application/End Users
1.3.1 United States Systemic Mycoses Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Histoplasmosis
1.3.3 Coccidioidomycosis
1.3.4 Pneumocystosis
1.3.5 Opportunistic infections
1.3.6 Other
1.4 United States Systemic Mycoses Market by Region
1.4.1 United States Systemic Mycoses Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Systemic Mycoses Status and Prospect (2012-2022)
1.4.3 Southwest Systemic Mycoses Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Systemic Mycoses Status and Prospect (2012-2022)
1.4.5 New England Systemic Mycoses Status and Prospect (2012-2022)
1.4.6 The South Systemic Mycoses Status and Prospect (2012-2022)
1.4.7 The Midwest Systemic Mycoses Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Systemic Mycoses (2012-2022)
1.5.1 United States Systemic Mycoses Sales and Growth Rate (2012-2022)
1.5.2 United States Systemic Mycoses Revenue and Growth Rate (2012-2022)

2 United States Systemic Mycoses Market Competition by Players/Suppliers
2.1 United States Systemic Mycoses Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Systemic Mycoses Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Systemic Mycoses Average Price by Players/Suppliers (2012-2017)
2.4 United States Systemic Mycoses Market Competitive Situation and Trends
2.4.1 United States Systemic Mycoses Market Concentration Rate
2.4.2 United States Systemic Mycoses Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Systemic Mycoses Manufacturing Base Distribution, Sales Area, Product Type

3 United States Systemic Mycoses Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Systemic Mycoses Sales and Market Share by Region (2012-2017)
3.2 United States Systemic Mycoses Revenue and Market Share by Region (2012-2017)
3.3 United States Systemic Mycoses Price by Region (2012-2017)

4 United States Systemic Mycoses Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Systemic Mycoses Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Systemic Mycoses Revenue and Market Share by Type (2012-2017)
4.3 United States Systemic Mycoses Price by Type (2012-2017)
4.4 United States Systemic Mycoses Sales Growth Rate by Type (2012-2017)

5 United States Systemic Mycoses Sales (Volume) by Application (2012-2017)
5.1 United States Systemic Mycoses Sales and Market Share by Application (2012-2017)
5.2 United States Systemic Mycoses Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Systemic Mycoses Players/Suppliers Profiles and Sales Data
6.1 Moxifloxacin
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Systemic Mycoses Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Moxifloxacin Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Indus Pharma Pvt. Ltd.
6.2.2 Systemic Mycoses Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Indus Pharma Pvt. Ltd. Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Cosmopack Pvt Ltd
6.3.2 Systemic Mycoses Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Cosmopack Pvt Ltd Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merind Limited
6.4.2 Systemic Mycoses Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merind Limited Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Alice Healthcare (P) Ltd
6.5.2 Systemic Mycoses Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Alice Healthcare (P) Ltd Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Intas Laboratories Pvt Ltd
6.6.2 Systemic Mycoses Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Intas Laboratories Pvt Ltd Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Wockhardt Ltd (Merind Limited)
6.7.2 Systemic Mycoses Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Wockhardt Ltd (Merind Limited) Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Ofloxacin
6.8.2 Systemic Mycoses Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Ofloxacin Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Alpa Laboratories Ltd
6.9.2 Systemic Mycoses Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Alpa Laboratories Ltd Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Vishnu Natural Herbs (P) Ltd
6.10.2 Systemic Mycoses Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Vishnu Natural Herbs (P) Ltd Systemic Mycoses Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Benzalkonium Chloride

7 Systemic Mycoses Manufacturing Cost Analysis
7.1 Systemic Mycoses Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Systemic Mycoses

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Systemic Mycoses Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Systemic Mycoses Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Systemic Mycoses Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Systemic Mycoses Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Systemic Mycoses Sales Volume Forecast by Type (2017-2022)
11.3 United States Systemic Mycoses Sales Volume Forecast by Application (2017-2022)
11.4 United States Systemic Mycoses Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Systemic Mycoses
Figure United States Systemic Mycoses Market Size (K Units) by Type (2012-2022)
Figure United States Systemic Mycoses Sales Volume Market Share by Type (Product Category) in 2016
Figure Decadron Product Picture
Figure Prednisone Product Picture
Figure Dexamethasone Product Picture
Figure Trexall Product Picture
Figure Other Product Picture
Figure United States Systemic Mycoses Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Systemic Mycoses by Application in 2016
Figure Histoplasmosis Examples
Table Key Downstream Customer in Histoplasmosis
Figure Coccidioidomycosis Examples
Table Key Downstream Customer in Coccidioidomycosis
Figure Pneumocystosis Examples
Table Key Downstream Customer in Pneumocystosis
Figure Opportunistic infections Examples
Table Key Downstream Customer in Opportunistic infections
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Systemic Mycoses Market Size (Million USD) by Region (2012-2022)
Figure The West Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Systemic Mycoses Sales (K Units) and Growth Rate (2012-2022)
Figure United States Systemic Mycoses Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Systemic Mycoses Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Systemic Mycoses Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Systemic Mycoses Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Systemic Mycoses Sales Share by Players/Suppliers
Figure 2017 United States Systemic Mycoses Sales Share by Players/Suppliers
Figure United States Systemic Mycoses Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Systemic Mycoses Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Systemic Mycoses Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Systemic Mycoses Revenue Share by Players/Suppliers
Figure 2017 United States Systemic Mycoses Revenue Share by Players/Suppliers
Table United States Market Systemic Mycoses Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Systemic Mycoses Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Systemic Mycoses Market Share of Top 3 Players/Suppliers
Figure United States Systemic Mycoses Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Systemic Mycoses Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Systemic Mycoses Product Category
Table United States Systemic Mycoses Sales (K Units) by Region (2012-2017)
Table United States Systemic Mycoses Sales Share by Region (2012-2017)
Figure United States Systemic Mycoses Sales Share by Region (2012-2017)
Figure United States Systemic Mycoses Sales Market Share by Region in 2016
Table United States Systemic Mycoses Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Systemic Mycoses Revenue Share by Region (2012-2017)
Figure United States Systemic Mycoses Revenue Market Share by Region (2012-2017)
Figure United States Systemic Mycoses Revenue Market Share by Region in 2016
Table United States Systemic Mycoses Price (USD/Unit) by Region (2012-2017)
Table United States Systemic Mycoses Sales (K Units) by Type (2012-2017)
Table United States Systemic Mycoses Sales Share by Type (2012-2017)
Figure United States Systemic Mycoses Sales Share by Type (2012-2017)
Figure United States Systemic Mycoses Sales Market Share by Type in 2016
Table United States Systemic Mycoses Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Systemic Mycoses Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Systemic Mycoses by Type (2012-2017)
Figure Revenue Market Share of Systemic Mycoses by Type in 2016
Table United States Systemic Mycoses Price (USD/Unit) by Types (2012-2017)
Figure United States Systemic Mycoses Sales Growth Rate by Type (2012-2017)
Table United States Systemic Mycoses Sales (K Units) by Application (2012-2017)
Table United States Systemic Mycoses Sales Market Share by Application (2012-2017)
Figure United States Systemic Mycoses Sales Market Share by Application (2012-2017)
Figure United States Systemic Mycoses Sales Market Share by Application in 2016
Table United States Systemic Mycoses Sales Growth Rate by Application (2012-2017)
Figure United States Systemic Mycoses Sales Growth Rate by Application (2012-2017)
Table Moxifloxacin Basic Information List
Table Moxifloxacin Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Moxifloxacin Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Moxifloxacin Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Moxifloxacin Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Indus Pharma Pvt. Ltd. Basic Information List
Table Indus Pharma Pvt. Ltd. Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Indus Pharma Pvt. Ltd. Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Indus Pharma Pvt. Ltd. Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Indus Pharma Pvt. Ltd. Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Cosmopack Pvt Ltd Basic Information List
Table Cosmopack Pvt Ltd Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cosmopack Pvt Ltd Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Cosmopack Pvt Ltd Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Cosmopack Pvt Ltd Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Merind Limited Basic Information List
Table Merind Limited Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merind Limited Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Merind Limited Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Merind Limited Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Alice Healthcare (P) Ltd Basic Information List
Table Alice Healthcare (P) Ltd Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alice Healthcare (P) Ltd Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Alice Healthcare (P) Ltd Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Alice Healthcare (P) Ltd Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Intas Laboratories Pvt Ltd Basic Information List
Table Intas Laboratories Pvt Ltd Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Intas Laboratories Pvt Ltd Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Intas Laboratories Pvt Ltd Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Intas Laboratories Pvt Ltd Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Wockhardt Ltd (Merind Limited) Basic Information List
Table Wockhardt Ltd (Merind Limited) Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Wockhardt Ltd (Merind Limited) Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Wockhardt Ltd (Merind Limited) Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Wockhardt Ltd (Merind Limited) Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Ofloxacin Basic Information List
Table Ofloxacin Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ofloxacin Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Ofloxacin Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Ofloxacin Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Alpa Laboratories Ltd Basic Information List
Table Alpa Laboratories Ltd Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alpa Laboratories Ltd Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Alpa Laboratories Ltd Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Alpa Laboratories Ltd Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Vishnu Natural Herbs (P) Ltd Basic Information List
Table Vishnu Natural Herbs (P) Ltd Systemic Mycoses Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vishnu Natural Herbs (P) Ltd Systemic Mycoses Sales Growth Rate (2012-2017)
Figure Vishnu Natural Herbs (P) Ltd Systemic Mycoses Sales Market Share in United States (2012-2017)
Figure Vishnu Natural Herbs (P) Ltd Systemic Mycoses Revenue Market Share in United States (2012-2017)
Table Benzalkonium Chloride Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Systemic Mycoses
Figure Manufacturing Process Analysis of Systemic Mycoses
Figure Systemic Mycoses Industrial Chain Analysis
Table Raw Materials Sources of Systemic Mycoses Major Players/Suppliers in 2016
Table Major Buyers of Systemic Mycoses
Table Distributors/Traders List
Figure United States Systemic Mycoses Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Systemic Mycoses Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Systemic Mycoses Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Systemic Mycoses Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Systemic Mycoses Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Systemic Mycoses Sales Volume (K Units) Forecast by Type in 2022
Table United States Systemic Mycoses Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Systemic Mycoses Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Systemic Mycoses Sales Volume (K Units) Forecast by Application in 2022
Table United States Systemic Mycoses Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Systemic Mycoses Sales Volume Share Forecast by Region (2017-2022)
Figure United States Systemic Mycoses Sales Volume Share Forecast by Region (2017-2022)
Figure United States Systemic Mycoses Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources